The effect of L-arginine and creatine on vascular function and homocysteine metabolism
- PMID: 19651674
- PMCID: PMC2840406
- DOI: 10.1177/1358863X08100834
The effect of L-arginine and creatine on vascular function and homocysteine metabolism
Abstract
Studies with L-arginine supplementation have shown inconsistent effects on endothelial function. The generation of guanidinoacetate (GAA) from L-arginine with subsequent formation of creatine and homocysteine and consumption of methionine may reduce the pool of L-arginine available for nitric oxide generation. Experimental studies suggest that creatine supplementation might block this pathway. We sought to determine the effects of L-arginine, creatine, or the combination on endothelium-dependent vasodilation and homocysteine metabolism in patients with coronary artery disease. Patients with coronary artery disease were randomized to L-arginine (9 g/day), creatine (21 g/day), L-arginine plus creatine, or placebo for 4 days (n = 26-29/group). Brachial artery flow-mediated dilation and plasma levels of L-arginine, creatine, homocysteine, methionine, and GAA were measured at baseline and follow-up. L-arginine and creatine supplementation had no effects on vascular function. L-arginine alone increased GAA (p < 0.01) and the ratio of homocysteine to methionine (p < 0.01), suggesting increased methylation demand. The combination of creatinine and L-arginine did not suppress GAA production or prevent the increase in homocysteine-to-methionine ratio. Unexpectedly, creatine supplementation (alone or in combination with L-arginine) was associated with an 11-20% increase in homocysteine concentration (p < 0.05), which was not attributable to worsened renal function, providing evidence against an effect of creatine on decreasing methylation demand. In conclusion, the present study provides no evidence that L-arginine supplementation improves endothelial function and suggests that l-arginine may increase methylation demand. Creatine supplementation failed to alter the actions of L-arginine on vascular function or suppress methylation demand. The unexpected increase in homocysteine levels following creatine supplementation could have adverse effects and merits further study, since creatine is a commonly used dietary supplement.
Figures
Similar articles
-
Effect of post-ruminal guanidinoacetic acid supplementation on creatine synthesis and plasma homocysteine concentrations in cattle.J Anim Sci. 2020 Mar 1;98(3):skaa072. doi: 10.1093/jas/skaa072. J Anim Sci. 2020. PMID: 32152623 Free PMC article.
-
L-arginine increases plasma homocysteine in apoE-/-/iNOS-/- double knockout mice.Cell Mol Biol (Noisy-le-grand). 2004 Dec;50(8):903-9. Cell Mol Biol (Noisy-le-grand). 2004. PMID: 15704254
-
Effect of guanidinoacetic acid supplementation on nitrogen retention and methionine methyl group flux in growing steers fed corn-based diets.J Anim Sci. 2022 Oct 1;100(10):skac283. doi: 10.1093/jas/skac283. J Anim Sci. 2022. PMID: 36029022 Free PMC article.
-
The effect of homocysteine-lowering therapy with folic acid on flow-mediated vasodilation in patients with coronary artery disease: a meta-analysis of randomized controlled trials.Atherosclerosis. 2014 Jul;235(1):31-5. doi: 10.1016/j.atherosclerosis.2014.03.032. Epub 2014 Apr 18. Atherosclerosis. 2014. PMID: 24814647 Review.
-
Safety of Dietary Guanidinoacetic Acid: A Villain of a Good Guy?Nutrients. 2021 Dec 24;14(1):75. doi: 10.3390/nu14010075. Nutrients. 2021. PMID: 35010949 Free PMC article. Review.
Cited by
-
Productive and metabolomic consequences of arginine supplementation in sows during different gestation periods in two different seasons.J Anim Sci Biotechnol. 2024 Sep 19;15(1):121. doi: 10.1186/s40104-024-01079-4. J Anim Sci Biotechnol. 2024. PMID: 39294768 Free PMC article.
-
Plasma Metabolome Analysis Suggests That L-Arginine Supplementation Affects Microbial Activity Resulting in a Decrease in Trimethylamine N-oxide-A Randomized Controlled Trial in Healthy Overweight Adults with Cardiometabolic Risk Factors.Curr Dev Nutr. 2023 Nov 20;7(12):102038. doi: 10.1016/j.cdnut.2023.102038. eCollection 2023 Dec. Curr Dev Nutr. 2023. PMID: 38162999 Free PMC article.
-
The Evolving Applications of Creatine Supplementation: Could Creatine Improve Vascular Health?Nutrients. 2020 Sep 16;12(9):2834. doi: 10.3390/nu12092834. Nutrients. 2020. PMID: 32947909 Free PMC article. Review.
-
The Relationship Between Creatine and Whey Protein Supplements Consumption and Anesthesia in Rats.Anesth Pain Med. 2016 Feb 13;6(1):e32648. doi: 10.5812/aapm.32648. eCollection 2016 Feb. Anesth Pain Med. 2016. PMID: 27110533 Free PMC article.
-
L-arginine as a nutritional prophylaxis against vascular endothelial dysfunction with aging.J Cardiovasc Pharmacol Ther. 2010 Mar;15(1):17-23. doi: 10.1177/1074248409354599. Epub 2010 Jan 6. J Cardiovasc Pharmacol Ther. 2010. PMID: 20053922 Free PMC article. Review.
References
-
- Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long- term outcome of coronary heart disease. Circulation. 2000;101:1899–1906. - PubMed
-
- Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101:948–954. - PubMed
-
- Gokce N, Keaney JF, Jr, Menzoian JO, Watkins M, Hunter L, Duffy SJ, Vita JA. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function. Circulation. 2002;105:1567–1572. - PubMed
-
- Girerd XJ, Hirsch AT, Cooke JP, Dzau VJ, Creager MA. L-Arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res. 1990;67:1301–1308. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL083269-01A1/HL/NHLBI NIH HHS/United States
- P50 HL083801/HL/NHLBI NIH HHS/United States
- R01 HL083269/HL/NHLBI NIH HHS/United States
- HL60886/HL/NHLBI NIH HHS/United States
- P01 HL081587/HL/NHLBI NIH HHS/United States
- P01 HL081587-050005/HL/NHLBI NIH HHS/United States
- P01 HL060886/HL/NHLBI NIH HHS/United States
- R01 HL075795-03/HL/NHLBI NIH HHS/United States
- P50 HL083801-03/HL/NHLBI NIH HHS/United States
- P01 HL081587-010005/HL/NHLBI NIH HHS/United States
- R01 HL075795/HL/NHLBI NIH HHS/United States
- R01 HL075795-02/HL/NHLBI NIH HHS/United States
- R01 HL083269-03/HL/NHLBI NIH HHS/United States
- P50 HL083801-020001/HL/NHLBI NIH HHS/United States
- K12 HL083781-01/HL/NHLBI NIH HHS/United States
- P01 HL081587-040005/HL/NHLBI NIH HHS/United States
- HL15157-31/HL/NHLBI NIH HHS/United States
- P01 HL081587-020005/HL/NHLBI NIH HHS/United States
- HL55993/HL/NHLBI NIH HHS/United States
- P50 HL055993/HL/NHLBI NIH HHS/United States
- K12 HL083781-02/HL/NHLBI NIH HHS/United States
- P50 HL083801-01/HL/NHLBI NIH HHS/United States
- K12 HL083781/HL/NHLBI NIH HHS/United States
- P50 HL083801-010001/HL/NHLBI NIH HHS/United States
- HL083781/HL/NHLBI NIH HHS/United States
- R01 HL083269-04/HL/NHLBI NIH HHS/United States
- P50 HL083801-04/HL/NHLBI NIH HHS/United States
- HL75795/HL/NHLBI NIH HHS/United States
- HL083269/HL/NHLBI NIH HHS/United States
- R01 HL083269-02/HL/NHLBI NIH HHS/United States
- R01 HL075795-05/HL/NHLBI NIH HHS/United States
- K12 HL083781-03/HL/NHLBI NIH HHS/United States
- P50 HL083801-030001/HL/NHLBI NIH HHS/United States
- R01 HL075795-01/HL/NHLBI NIH HHS/United States
- P50 HL083801-02/HL/NHLBI NIH HHS/United States
- P50 HL083801-040001/HL/NHLBI NIH HHS/United States
- P01 HL081587-030005/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
